politics and governance | January 07, 2026

Dr. David Miller, MD – Dallas, TX

  • Predictors of Long-term Survival in Endometrial CancerDecember 2023

  • State-of-the-Art Management of Advanced or Recurrent Endometrial CancerNovember 2023

  • Radiation Therapy for Medically Inoperable Endometrial CancerOctober 2023

  • Outcomes in Older Women With Endometrial CancerAugust 2023

  • Quality of Life and Sexual Health in Endometrial Cancer SurvivorsJuly 2023

  • Frequently Asked Questions: Precision Medicine in Gynecologic CancersJune 2023

  • Minimally Invasive Surgery in Endometrial Cancer: Long-term Recurrence and SurvivalJune 2023

  • Applying Current Precision Medicine Strategies for the Treatment of Gynecologic CancersJune 2023

  • Applying Current Precision Medicine Strategies for the Treatment of Gynecologic CancersJune 2023

  • Integrating Biomarkers and Guideline-Aligned Treatment Approaches Into Patient-Centered Care for Advanced/Metastatic Endometrial CancerMay 2023

  • Expert Commentary and Insight on Key Data From SGO 2023 Informing Treatment for Endometrial, Cervical, and Ovarian CancersMay 2023

  • Expert Insight on New Data From SGO 2023 Informing Treatment for Endometrial, Cervical, and Ovarian CancersMay 2023

  • Slides: Expert Insight on Practice Changing Data From SGO 2023 Informing Treatment for Endometrial, Cervical, and Ovarian CancersMay 2023

  • Expert Analyses of Key Clinical Developments and Updates Across Gynecologic MalignanciesJanuary 2023

  • Endometrial Cancer Consult: Optimal Management Across the Disease ContinuumJanuary 2023

  • Treating Gynecologic Cancers: Current Approaches to Patient CareDecember 2022

  • CCO 2022 Global Conference Coverage: Gynecologic Cancer UpdatesNovember 2022

  • Evolving Treatment Paradigms for Gynecologic Malignancies: Application for Current and Future PracticeJune 2022

  • Gynecologic Cancers: Expert Guidance for Community PracticeMay 2022

  • FAQs: Integrating Novel Therapies Into the Management of Gynecologic CancersMay 2022

  • Expert Insight on Key Data From SGO 2022 Informing Treatment for Endometrial, Ovarian, and Cervical CancersMay 2022

  • CCO 2021 Global Conference Coverage: Gynecologic Cancer UpdatesNovember 2021

  • Expert Commentary and Insight on Key Data From SGO 2023 Informing Treatment for Endometrial, Cervical, and Ovarian CancersMay 2021

  • Existing and Emerging Strategies in the Management of Patients with Uterine SarcomasMarch 2017

  • Join now to see all